Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern

Christophe Le Terrier^{1

2}, Patrice Nordmann^{1

3

4}, Chloé Buchs¹, Doris Yoong Wen Di⁵, Gian Maria Rossolini^{6

7}, Roger Stephan⁸, Mariana Castanheira⁹, Laurent Poirel^{1

3}

Affiliations

¹ Emerging Antibiotic Resistance, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Chemin du Musée 18, CH-1700 Fribourg, Switzerland.
² Division of Intensive Care Unit, University Hospitals of Geneva, Geneva, Switzerland.
³ Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland.
⁴ Institute for Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁵ School of Earth Sciences and Environmental Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
⁶ Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.
⁷ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
⁸ Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 272, CH-8057 Zurich, Switzerland.
⁹ JMI Laboratories, North Liberty, IA, USA.

Christophe Le Terrier et al. J Antimicrob Chemother. 2023.

. 2023 Sep 5;78(9):2382-2384.

doi: 10.1093/jac/dkad210.

Christophe Le Terrier^{1

2}, Patrice Nordmann^{1

3

4}, Chloé Buchs¹, Doris Yoong Wen Di⁵, Gian Maria Rossolini^{6

7}, Roger Stephan⁸, Mariana Castanheira⁹, Laurent Poirel^{1

3}

¹ Emerging Antibiotic Resistance, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Chemin du Musée 18, CH-1700 Fribourg, Switzerland.
² Division of Intensive Care Unit, University Hospitals of Geneva, Geneva, Switzerland.
³ Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland.
⁴ Institute for Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁵ School of Earth Sciences and Environmental Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
⁶ Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.
⁷ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
⁸ Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 272, CH-8057 Zurich, Switzerland.
⁹ JMI Laboratories, North Liberty, IA, USA.

No abstract available

References

1. Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis 2019; 69Suppl 7: S521–8. 10.1093/cid/ciz824 - DOI - PMC - PubMed
1. Le Terrier C, Masseron A, Uwaezuoke NSet al. Wide spread of carbapenemase-producing bacterial isolates in a Nigerian environment. J Glob Antimicrob Resist 2020; 21: 321–3. 10.1016/j.jgar.2019.10.014 - DOI - PubMed
1. Bush K, Bradford PA. Interplay between β-lactamases and new β-lactamase inhibitors. Nat Rev Microbiol 2019; 17: 295–306. 10.1038/s41579-019-0159-8 - DOI - PubMed
1. Hamrick JC, Docquier JD, Uehara Tet al. VNRX-5133 (taniborbactam), a broad-spectrum inhibitor of serine- and metallo-β-lactamases, restores activity of cefepime in Enterobacterales and Pseudomonas aeruginosa. Antimicrob Agents Chemother 2020; 64: e01963-19. 10.1128/AAC.01963-19 - DOI - PMC - PubMed
1. Le Terrier C, Gruenig V, Fournier Cet al. NDM-9 resistance to taniborbactam. Lancet Infect Dis 2023; 23: 401–2. 10.1016/S1473-3099(23)00069-5 - DOI - PubMed